Data Report
Accepted on 09 Jul 2024
History of Trastuzumab: A Case Study in Health Technology Reassessment and natural Disinvestment in Veneto Region
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1406351
Type at least 3 characters
1,864 articles
Articles
Original Research
Accepted on 08 Jul 2024
Association between medication complexity and follow-up care attendance: insights from a retrospective multicenter cohort study across 1,223 Chinese hospitals
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1448986
Original Research
Accepted on 08 Jul 2024
Safety assessment of neurokinin-1 receptor antagonist: real-world adverse events analysis from the FAERS database
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413709
Original Research
Published on 08 Jul 2024
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1416985
- 240 views
Original Research
Accepted on 05 Jul 2024
Level of Medication Adherence and its Determinants of Cardiovascular Disease Patients Attending at Specialized Teaching Hospitals of Amhara Regional State, Ethiopia: A Multicenter Cross-Sectional Study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1422703
Original Research
Published on 05 Jul 2024
A point prevalence survey and monitoring indicator research on the second batch of national key monitoring and rational use drugs
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1416010
- 182 views
Review
Accepted on 02 Jul 2024
An Overview of Traditional Smoking Cessation Interventions and Ecigarettes
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1293062
Original Research
Accepted on 02 Jul 2024
A Bayesian Framework for Virtual Comparative Trials and Bioequivalence Assessment
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1404619
Original Research
Accepted on 02 Jul 2024
Treatment satisfaction and medication adherence and predictors among patients with heart failure in Ethiopia: A hospital-based cross-sectional study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1399177
Original Research
Published on 02 Jul 2024
Patient preferences for generic substitution policies: a discrete choice experiment in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1400156
- 224 views
Original Research
Published on 28 Jun 2024
Development and validation of the BMQ-AIR©: a screening tool for assessing patients’ treatment beliefs about switching to anti-inflammatory reliever (AIR) therapy
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1351851
- 217 views
Original Research
Published on 27 Jun 2024
Does China’s national volume-based drug procurement policy promote or hinder pharmaceutical innovation?
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1392239
- 296 views
Original Research
Accepted on 26 Jun 2024
Signal Mining and Analysis of Trifluridine/Tipiracil Adverse Events Based on Real-World Data from the FAERS Database
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1399998
Original Research
Published on 26 Jun 2024
Physicians’ perceptions and awareness of adverse effects of proton pump inhibitors and impact on prescribing patterns
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1383698
- 268 views
Original Research
Accepted on 24 Jun 2024
Identifying and presenting key country-specific indicators related to medication adherence: A comprehensive study across European countries
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1390629
Original Research
Published on 24 Jun 2024
Unraveling elements of value-based pricing from a pharmaceutical industry’s perspective: a scoping review
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1298923
- 410 views